GlobalData on MSN
FDA clears C2N Diagnostics’ early Alzheimer’s assessment test
C2N’s Alzheimer’s test is the first to be FDA-cleared for use in patients as young as 40 who present with cognitive ...
TheGrio on MSN
Black Americans face higher Alzheimer’s risk. Now, NIH funding for research into why is being cut
The Trump administration’s rollback of DEI-related research is now affecting studies examining Black communities higher risk for Alzheimer’s. Black communities ...
Discover how people with sleep disturbance and mild cognitive impairment who took 5,000 IU of vitamin D daily performed ...
When Congress returns from August recess, lawmakers will face a legislative agenda crowded with funding deadlines and ...
Gardner says women are more likely to have or develop Alzheimer’s disease and men are more likely to develop vascular ...
For Rusty Martin, hearing a devastating diagnosis was coupled with relief at finally having an explanation, writes Dr. Yogesh Shah.
Alzheimer’s dementia is generally more prevalent in women than in men, and doctors believe that one reason why is the sudden ...
Canton Repository on MSNOpinion
I have Alzheimer's. I'm deciding to die on my terms. | Opinion
When I was diagnosed with early-onset Alzheimer's, I decided I would not let the disease slowly kill me. Instead, I would ...
The FDA has cleared PrecivityAD2, a single blood test designed to help health care professionals rule in or rule out an ...
Treatment with new oral anticoagulants (NOAC) may help slow the cognitive decline rate of people with both Alzheimer's ...
Experts have spoken about the signs and symptoms, whether there are gender differences and how people with Alzheimer’s can be ...
The U.S. Food and Drug Administration (FDA) has cleared for marketing an innovative blood test with underlying technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results